Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer

K. R. Haisley, K. D. Hart, N. Nabavizadeh, K. G. Bensch, Gina Vaccaro, Charles Thomas, Paul Schipper, John Hunter, James Dolan

Research output: Contribution to journalArticle

11 Scopus citations

Fingerprint Dive into the research topics of 'Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences